We are live on ! Find out more
JFG

Jefferies Financial Group Portfolio holdings

AUM $15.2B
1-Year Est. Return 55.75%
This Fund
S&P 500
This Quarter Est. Return
+21.65%
1 Year Est. Return
+55.75%
3 Year Est. Return
+134.64%
5 Year Est. Return
+55.21%
10 Year Est. Return
+628.45%
AUM
$15.2B
AUM Growth
+$586M
Cap. Flow
+$1.26B
Cap. Flow %
8.33%
Top 10 Hldgs %
30.61%
Holding
2,149
New
466
Increased
491
Reduced
450
Closed
528

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$380M
2
AAPL icon
Apple
AAPL
+$147M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$106M
4
TMO icon
Thermo Fisher Scientific
TMO
+$66.5M
5
IREN icon
Iris Energy
IREN
+$58.4M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$131M
2
ASH icon
Ashland
ASH
+$106M
3
ADI icon
Analog Devices
ADI
+$83.9M
4
XRT icon
State Street SPDR S&P Retail ETF
XRT
+$78.3M
5
JCI icon
Johnson Controls International
JCI
+$70.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 50.01%
2 Healthcare 12.03%
3 Technology 11.01%
4 Consumer Discretionary 5.82%
5 Financials 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NE icon
1801
Noble Corp
NE
$6.84B
– –
-5,911
Closed -$290K
NGVC icon
1802
Vitamin Cottage Natural Grocers
NGVC
$685M
– –
-7,912
Closed -$205K
NI icon
1803
CALL
NiSource
NI
$18.9B
– –
-49,600
Closed -$2.31M
NI icon
1804
NiSource
NI
$18.9B
– –
-228
Closed -$10.6K
NIC icon
1805
Nicolet Bankshares
NIC
$3.53B
– –
-1,799
Closed -$267K
NIO icon
1806
NIO
NIO
$8.97B
– –
-4,094
Closed -$24.7K
NIO icon
1807
PUT
NIO
NIO
$8.97B
– –
-400,000
Closed -$2.41M
NMRA icon
1808
Neumora Therapeutics
NMRA
$127M
– –
-33,044
Closed -$64.4K
NOV icon
1809
CALL
NOV
NOV
$7.08B
– –
-177,100
Closed -$3.33M
NOV icon
1810
NOV
NOV
$7.08B
– –
-57,844
Closed -$1.09M
NSC icon
1811
Norfolk Southern
NSC
$70.3B
– –
-138,093
Closed -$39.6M
NSIT icon
1812
Insight Enterprises
NSIT
$4.67B
– –
-3,346
Closed -$224K
NSSC icon
1813
Napco Security Technologies
NSSC
$1.28B
– –
-18,558
Closed -$731K
NTNX icon
1814
CALL
Nutanix
NTNX
$18.4B
– –
-120,000
Closed -$4.56M
NUE icon
1815
Nucor
NUE
$56.1B
– –
-16,343
Closed -$2.76M
NVAX icon
1816
Novavax
NVAX
$1.75B
– –
-673,120
Closed -$5.48M
NVO
1817
Novo Nordisk
NVO
$171B
– –
-16,524
Closed -$607K
NVST icon
1818
Envista
NVST
$3.85B
– –
-25,500
Closed -$647K
NVT icon
1819
nVent Electric
NVT
$26.6B
– –
-39,340
Closed -$4.65M
NWL icon
1820
Newell Brands
NWL
$2.31B
– –
-30,975
Closed -$106K
NXT icon
1821
PUT
Nextpower Inc. Common Stock
NXT
$12.3B
– –
-105,600
Closed -$12.7M
NYT icon
1822
New York Times
NYT
$10.3B
– –
-6,980
Closed -$584K
OBDC icon
1823
PUT
Blue Owl Capital
OBDC
$5.33B
– –
-25,000
Closed -$277K
OCGN icon
1824
Ocugen
OCGN
$346M
– –
-75,917
Closed -$137K
OCUL icon
1825
CALL
Ocular Therapeutix
OCUL
$2.12B
– –
-22,100
Closed -$187K
71 72
73
74 75

Similar funds

IFP
Independent Franchise Partners London, United Kingdom $15.2B AUM 1.56% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $15.3B AUM 25.33% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
VIM
Vinva Investment Management Sydney, Australia $15.1B AUM 39.47% 1-Year Est. Return

Jefferies Financial Group's Q2 2026 Portfolio in Review

As of Q2 2026, Jefferies Financial Group held 2,149 positions worth $15.2B, up 4% from $14.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Jefferies Financial Group deployed $1.26B of net new capital in Q2 2026, opening 466 new positions and adding to 491 existing holdings. Its largest new stake was CG Oncology: 769,947 shares worth $54.7M.

By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, down from 61% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Broadcom, an estimated $131M trimmed.

  • Jefferies Financial Group's largest Q2 2026 buy was CG Oncology: 769,947 shares worth $54.7M.
  • Jefferies Financial Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $380M increase.
  • Jefferies Financial Group's biggest Q2 2026 reduction was Broadcom, cutting an estimated $131M.
  • Jefferies Financial Group fully exited Ashland in Q2 2026, selling an estimated $106M.
  • Jefferies Financial Group's ten largest holdings make up 31% of its $15.2B portfolio in Q2 2026.
  • Jefferies Financial Group opened 466 new positions and closed 528 in Q2 2026.
  • Jefferies Financial Group's portfolio value rose 4% quarter-over-quarter to $15.2B.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.